Athersys, Inc. (ATHX) Rating Reiterated by Maxim Group
's stock had its "buy" rating reissued by equities researchers at Maxim Group in a report released on Sunday, AnalystRatings.Net reports. They currently have a $5.00 price target on the biopharmaceutical company's stock.
from Biotech News
0 Comments